Loading
Latest filing published 13 Feb 2023 for Bluejay Diagnostics, Inc., €11k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Fred S. Zeidman across 3 companies, led by Good Works II Acquisition Corp., Bluejay Diagnostics, Inc. and Straight Path Communications Inc. We count 4 filings; the first trade dates from 5 January 2016 and the latest from 1 February 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 13 February 2023 with a share grant (€11k) in Bluejay Diagnostics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations